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Edited by Felix WielandAbstract DJ-1 is secreted into the serum and plasma of pa-
tients with various diseases. In this study, DJ-1 was found to
be secreted into culture media of various cells and the amount
of wild-type DJ-1 secreted was two-fold greater than that of mu-
tant DJ-1 of cysteine at 106 (C106). Furthermore, the oxidative
status of more than 90% of the DJ-1 secreted from HeLa cells
was SOH and SO2H forms of C106. A portion of DJ-1 in cells
was localized in microdomains of the membrane. These ﬁndings
suggest that DJ-1 is secreted through microdomains and that
oxidation of DJ-1 at C106 facilitates the secretion.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Parkinsons disease1. Introduction
DJ-1 was ﬁrst identiﬁed by our group as a novel candidate of
the oncogene product that transformed mouse NIH3T3 cells in
cooperation with activated ras [1]. DJ-1 has been reported to
be a circulating tumor antigen in breast cancer [2] and to be
overexpressed in smoking-derived lung adenocarcinoma, pros-
tate cancer, and pancreas carcinoma [3–5]. DJ-1 has also been
reported to be a regulatory component of an RNA-binding
protein complex [6] and to be related to infertility [7–11]. Dele-
tion and point (L166P) mutations of DJ-1 have been shown to
be responsible for onset of familial Parkinsons disease,
PARK7 [12], and other homozygous and heterozygous muta-
tions of DJ-1 have been identiﬁed in patients with familial or
sporadic Parkinsons disease [13–15].
DJ-1 is a multi-functional protein and plays roles in tran-
scriptional regulation and anti-oxidative stress function, and
loss of its functions leads to the onset of Parkinsons disease
and cancer. Although DJ-1 does not directly bind to DNA,
DI-1 acts as a coactivator to activate various transcription fac-
tors, including the androgen receptor and p53, by sequestering
PIASxa, DJBP, Topors or PSF [16–19]. The anti-oxidative
stress function of DJ-1 is achieved through various mecha-
nisms: DJ-1 is self-oxidized at cysteine residues at amino acid
numbers 46, 53 and 106 (C46, C53 and C106, respectively)*Corresponding author. Fax: +81 11 706 4988.
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doi:10.1016/j.febslet.2008.06.043to eliminate reactive oxygen species [20–23]; DJ-1 transacti-
vates genes whose products contribute to the redox reaction,
including glutathione synthetase [24] and superoxide dismutase
type III [25]; and DJ-1 facilitates translocation of Nrf2, a mas-
ter transcription factor for anti-oxidation-related genes, to the
nucleus by sequestering Keap1, a negative regulator for Nrf2
[26].
Activity of DJ-1 seems to depend on its oxidized state. Of
the three cysteines, C106 is the most sensitive to oxidative
stress, and a mutant such as C106S DJ-1 in which a cysteine
residue has been substituted for serine has been shown to lose
the anti-oxidative stress function [27]. Furthermore, it has been
reported that oxidation of C106 as a sulﬁnic acid (SO2H) form
was necessary for DJ-1 to exert chaperone activity and that
further oxidation of C106 as the sulfonic acid (SO3H) form re-
sulted in loss of this activity [28]. Absence of the reduced form
of DJ-1 and presence of abnormally oxidized DJ-1 have been
found in brains of patients with Parkinsons disease [29], and
accumulation of highly oxidized DJ-1 has been found in pa-
tients with Parkinsons disease and in patients with Alzheimer
disease [30].
DJ-1 is localized both in the cytoplasm and nucleus and is
translocated by stress or mitogen stimulation of cells. After
UV irradiation or mitogen stimulation of cells, for instance,
DJ-1 is translocated to the nucleus. After oxidative stress such
as that caused by addition of H2O2 to cell culture, some of DJ-
1 is translocated to mitochondria [22,31]. Furthermore, it has
been reported that DJ-1 was secreted into the serum or plasma
of patients with breast cancer [2], stroke [32], a sporadic form
of Parkinsons disease [33,34] or familial amyloidotic polyneu-
ropathy [35] and was present in the semen of unfertilized rats
[7,8]. It has also been reported that DJ-1 was present in cere-
brospinal ﬂuid of patients with the sporadic form of Parkin-
sons disease and that the amount of DJ-1 in cerebrospinal
ﬂuid was greater in patients with a grade of Yahr 2 or 3 of Par-
kinsons disease, suggesting that DJ-1 acted as a protective fac-
tor against early stages of Parkinsons disease [36]. Although
the presence of DJ-1 in ﬂuid secreted from cells has been re-
ported as stated above, it is not clear whether DJ-1 was actu-
ally secreted from cells or was released from damaged cells.
In this study, we analyzed secretion of DJ-1 from cultured
cells. The results showed that DJ-1 was secreted from various
cells and that oxidation of DJ-1 at C106 facilitated the secre-
tion. The results also showed that DJ-1 was localized in micro-
domains.blished by Elsevier B.V. All rights reserved.
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2.1. Cells and secretion of DJ-1
Human SH-SY5Y and HeLa cells and mouse Flp-InNIH3T3 cells
(InVitrogen) harboring FLAG-tagged wild-type (WT) DJ-1 or C106S
DJ-1 as described previously [28] were cultured in Dulbeccos modiﬁed
Eagles medium with 10% calf serum. Cells were washed ﬁve times with
phosphate-buﬀered saline and cultured again in serum-free medium for
6 h. The culture medium was then centrifuged at 3000·g for 3 min at
4 C to remove cells and cell debris, and proteins in the medium were
precipitated with acetone. Precipitates were dissolved in a Laemmli
buﬀer and analyzed by Western blotting with a rabbit anti-DJ-1 poly-
clonal antibody [1] or with a mouse anti-FLAG antibody (M2, Sigma).
Filters were also reacted with anti-actin (Chemicon), anti-tubulin
(Chemicon) and anti-ﬁbronectin (Chemicon) antibodies. The proteins
on the membranes were then reacted with IRDye800- or Alexa
Fluor680-conjugated secondary antibodies followed by visualization
using an infrared imaging system (Odyssey, LI-COR).
The amount of DJ-1 in the medium was also measured by using a
Human DJ-1 ELISA kit (CycLex, Japan) according to the manufac-
turers protocol.
To assess cell viability or membrane integrity, LDH assays were car-
ried out using supernatants prepared from cultured SH-SY5Y or HeLa
cells as described above. Supernatants prepared from cells cultured in a
serum-free medium with 1 mM H2O2 for 6 h were used as a positiveA
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Fig. 1. Secretion of DJ-1. Human SH-SY5Y and HeLa cells were cultured in
activity (A) and proteins (B) in its supernatant were analyzed by an LDH
antibodies, respectively. After the reaction of membranes with secondary a
(Odyssey, LI-COR). ‘‘FN’’ represents ﬁbronectin.control. LDH assays were carried out using an LDL assay kit (Cyto-
Tox-ONE Homogeneous Membrane Integrity Assay kit, Promega)
according to the suppliers protocol. Brieﬂy, 300 ll of supernatant
was mixed with 300 ll of CytoTox-ONE reagent and incubated at
22 C for 10 min, and its ﬂuorescence intensity (Ex = 560 nm,
Em = 590 nm) was measured using a ﬂuorescent spectrophotometer
(F-2500, Hitachi).
2.2. Separation of the microdomain
Cells were dissolved in a buﬀer containing 0.5% NP40, 50 mM Tris–
HCl (pH 8.0), 120 mM NaCl, 150 lg/ml PMSF and 1% Triton X-100
and incubated on ice for 20 min. After centrifugation of the above mix-
tures at 1300·g for 5 min at 4 C, the supernatants were loaded on dis-
continuous sucrose density gradients consisting of 5%, 30% and 40% of
sucrose in a MES buﬀer containing 25 mMMES (pH 6.5) and 150 mM
NaCl and centrifuged at 39,000 rpm for 18 h using an SW41 rotor
(Beckman Coulter). After fractionation of gradients, aliquots of frac-
tions were analyzed by Western blotting with anti-FLAG, anti-DJ-1
and anti-caveolin 1 (BD/Transduction) antibodies.
2.3. Indirect immunoﬂuorescence
Cells were ﬁxed with 4% paraformaldehyde and reacted with rabbit
anti-DJ-1 polyclonal and mouse anti-caveolin 1 (BD/Transduction)
monoclonal antibodies. The cells were also stained with DAPI. The
cells were then reacted with a rhodamine-conjugated anti-rabbit IgG0 h 6 h
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a serum-free medium for 6 h. The medium was centrifuged, and LDH
assay kit and by Western blotting with anti-DJ-1 and anti-ﬁbronectin
ntibodies, proteins were visualized using an infrared imaging system
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laser ﬂuorescent microscope (Zeiz) or All-in-on microscope (Biorevo
BZ-9000, Keyence).
2.4. Identiﬁcation of oxidative states of C106 of DJ-1 by MALDI-TOF/
TOF-MS analysis
Supernatants from cultured HeLa cells were prepared as described
above and immunoprecipitated with a rabbit anti-DJ-1 polyclonal
antibody (ﬁnal concentration of 4 lg/ml), and immunoprecipitates
were separated on a 12.5% polyacrylamide gel. After the gel had been
stained with CBB, a band corresponding to DJ-1 was cut out, reduced,
alkylated with a buﬀer containing iodoacetamide, and digested with
trypsin. The peptide solutions were desalted, mixed with a-cyano-4-
hydroxycinnamic acid, and applied onto a target plate. MS/MS spectra
of the C106-containing peptide spanning 100–122 amino acids were
obtained using an Ultraﬂex (Brucker Daltonics) in reﬂector mode
and analyzed with ﬂexanalysis software (Brucker Daltonics). Protein
identiﬁcation was carried out with Mascot software against the data-
base of NIBI.
2.5. Statistical analyses
Data are expressed as means ± S.D. Statistical analyses were per-
formed using analysis of variance (one-way ANOVA) followed by un-
paired Students t-test.3. Results and discussion
3.1. Secretion of DJ-1 from various cultured cells
Human SH-SY5Y, HeLa, MCF7 and 293T cells and mouse
NIH3T3 cells expressing exogenously added FLAG-taggedNIH3T3-WT DJ-1
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Fig. 2. Eﬀect of oxidative stress on the secretion of wild-type DJ-1 and C106S
C106S DJ-1 (NIH3T3-WT DJ-1 and NIH3T3-C106S DJ-1 cells, respectively
for 6 h. (A) Proteins in the culture medium were analyzed by Western blotti
‘‘Cell’’ and ‘‘FN’’ represent protein samples extracted from cells and ﬁbro
measured using a DJ-1 ELISA kit.wild-type (WT) and C106S DJ-1 (NIH3Y3-WT DJ-1 cells
and NIH3T3-C106S DJ-1 cells, respectively) [27] were cultured
in the presence of 10% serum and then cultured in the absence
of serum for 6 h. To assess the absence of dead cells in the cul-
ture medium, LDH assays were carried out using cultured
supernatants. As a positive control, supernatants from cells
that had been treated with 1 mM H2O2 for 6 h were used
(Fig. 1A). The results showed that there was no LDL activity
in supernatants from SH-ST5Y and HeLa cells, indicating that
preparations of the medium were not contaminated with dead
cells. At various times after culture in the absence of serum,
proteins in the culture medium were analyzed by Western blot-
ting with anti-DJ-1, anti-actin, anti-tubulin and anti-ﬁbronec-
tin antibodies. No actin or tubulin was detected in any of the
samples (data not shown). Fibronectin was used as a positive
control of a secreted protein. DJ-1 was detected in the culture
media of all of the cells examined, and the results for SH-
SY5Y, HeLa, NIH3T3-WT DJ-1 and NIH3T3-C106S DJ-1
cells that had been cultured for 6 h in the absence of serum
are shown (Figs. 1B and 3A, lane 2). DJ-1 was detected in
the medium from 0.5 h after cells were cultured in the absence
of serum (data not shown).
To examine the eﬀect of oxidative stress on the secretion of
DJ-1, NIH3T3-WT DJ-1 and NIH3T3-C106S DJ-1 cells cul-
tured in serum-free medium were exposed to various amounts
of H2O2, and then exogenous FLAG-DJ-1 and endogenous
DJ-1 in the medium were analyzed by Western blotting with
anti-FLAG and anti-mouse DJ-1 antibodies, respectively,NIH3T3-C106S DJ-1
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DJ-1. Mouse NIH3T3 cell lines harboring FLAG-wild-type DJ-1 and
) were cultured in the absence of serum with various amounts of H2O2
ng with anti-FLAG, anti-mouse DJ-1 and anti-ﬁbronectin antibodies.
nectin, respectively. (B) Amount of DJ-1 in the culture medium was
2646 Y. Tsuboi et al. / FEBS Letters 582 (2008) 2643–2649and the amount of DJ-1 was measured by an ELISA (Fig. 2).
It was found that FLAG-WT-DJ-1 was secreted much more
than was FLAG-C106S DJ-1 but that exposure to H2O2 had
little eﬀect on the secretion of DJ-1 (Fig. 2A). Lower bands
of doublet bands observed in FLAG-WT-DJ-1 cells may beFig. 3. Oxidative status of secreted DJ-1. HeLa cells were cultured in a serum
with an anti-DJ-1 antibody and the precipitates were separated on a 12% poly
MALDI-TOF/TOF-MS as described in Section 2. Cysteine residues in the re
acid, can be covalently modiﬁed with iodoacetamide, which results in 56-Danon-speciﬁc bands. It is interesting that endogenous DJ-1
was also secreted from NIH3T3-WT DJ-1 cells but that secre-
tion of endogenous DJ-1 from NIH3T3-C106S DJ-1 cells was
not detected under this condition in. The quantity of DJ-1
measured by the ELISA corresponded to the results of-free medium for 6 h. Proteins in the medium were immunoprecipitated
acrylamide gel. A stained band corresponding to DJ-1 was analyzed by
duced state and oxidized to sulfenic and sulﬁnic acids, but not sulfonic
shifts of C106-containing peptides spanning 100–122 amino acids.
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NIH-C106S DJ-1 cells were about half of those secreted from
NIH-WT-DJ-1 cells, suggesting that oxidation of DJ-1 at C106
facilitates the secretion of DJ-1 from cells.
To examine the level of the oxidative state of C106 of se-
creted DJ-1, proteins in supernatants from HeLa cells were
immunoprecipitated with an anti-DJ-1 antibody and precipi-1 2 3 4 5 6
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and subjected to MALDI-TOF/TOF-MS analysis (Fig. 3). A
segment containing C106 had four peaks that correspond to
reduced and oxidized C106 as SOH, SO2H and SO3H, and
the amount of each form was quantiﬁed (Fig. 3A and B,
respectively). The results showed that amounts of reduced,7 8 9    10     11   12
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2648 Y. Tsuboi et al. / FEBS Letters 582 (2008) 2643–2649SOH, SO2H and SO3H forms of C106 were 3 ± 1.2, 54.0 ± 1.4,
41.5 ± 2.1 and 1.5 ± 0.6% of total forms, respectively (Fig. 3B).
Since DJ-1 with a reduced form of C106 was about 50–75% of
total forms in SH-SY5Y and NIH3T3 as described previously
[37], it is thought that oxidation of DJ-1 at C106 facilitates the
secretion of DJ-1 from cells.3.2. Localization of DJ-1 in microdomains
There are at least two pathways of protein secretion from
cells, classical and non-classical pathways. In a classical path-
way, a protein with a signal peptide at its N-terminus is se-
creted through the secretory granule or secretory vesicle. In a
non-classical pathway, the protein is secreted through micro-
domains that are composed of caveolae or rafts comprising
phospholipids, cholesterol, glycosphingolipids and cavaolin.
Since DJ-1 has no signal peptide, we examined the possibility
that DJ-1 is localized in microdomains. Proteins extracted
from HeLa cells with a buﬀer containing 1% Triton X-100
were loaded on a discontinuous sucrose density gradient and
centrifuged. Aliquots of factions were analyzed by Western
blotting with anti-DJ-1 and anti-cavaolin antibodies (Fig.
4A). Of 12 fractions, microdomains containing cavaolin were
included from fraction numbers 4–6 and a part of DJ-1 was
also found to be localized in these fractions. HeLa cells were
then stained with anti-DJ-1 and anti-cavaolin antibodies, and
DJ-1 and caveolin were visualized after reaction with rhoda-
mine and FITC-conjugated secondary antibodies, respectively
(Fig. 4B). Cavaolin was located at or near the cell surface, and
colors of some DJ-1 stained in red and caveolin stained in
green turned yellow, indicating that some DJ-1 was located
in microdomains containing caveolin. When NIH3T3-WT
DJ-1 and NIH3T3-C106S DJ-1 cells were similarly analyzed,
a larger amount of FLAG-WT DJ-1 than that of FLAG-
C106S DJ-1 was found to be localized in microdomains
(Fig. 4C). This phenomenon seems to be true for endogenous
DJ-1 in between NIH3T3-WT and NIH3T3-C106S DJ-1 cells.
Tunicamycin and pravastatin are inhibitors of classical and
non-classical pathways of secretion systems, respectively.
NIH3T3-WT DJ-1 cells were treated with either inhibitor dur-
ing culture, and FLAG-WT DJ-1 in the medium was analyzed
by Western blotting and ELISA (Fig. 4D-a and E, respec-
tively). After treatment of cells with pravastatin, factions con-
taining caveolin moved to the right, suggesting that
microdomain formation was partially disrupted (Fig. 4D-b).
The results showed that treatment of cells with tunicamycin
seemed to stimulate secretion of DJ-1 and that treatment of
cells with pravastatin, on the other hand, signiﬁcantly reduced
secretion of DJ-1, suggesting that a portion of DJ-1 was se-
creted through microdomains.
As described in Section 1, DJ-1 has been observed in serum,
plasma and cerebrospinal ﬂuid of patients with various dis-
eases [2,32–36]. Furthermore, DJ-1 has been shown to be
incorporated into cells when DJ-1 protein was injected into
the substantial nigra of rats or was added to a medium of
cultured SH-SY5Y cells [38]. These results suggest that DJ-1
shuttles between the inside and outside of cells.
In this study, we examined the secretion and secretion path-
way of DJ-1. We ﬁrst found that DJ-1 was actually secreted
from cells into the culture medium under the condition in
which cells did not die. We then found that the amount of
wild-type DJ-1 secreted was two-times greater than that ofC106S mutant DJ-1 but that further oxidation of DJ-1 by
treatment of cells with up to 400 lM H2O2, under the condi-
tion in which C106 of DJ-1 was oxidized as an SO3H form
did not enhance the secretion of DJ-1. Furthermore, the oxida-
tive status of more than half of the DJ-1 secreted from HeLa
cells was SOH and SO2H forms of C106. These results suggest
that oxidation of DJ-1 at C106 at least as an SO2H form facil-
itated the secretion of DJ-1.
Furthermore, a portion of DJ-1 was localized in microdo-
mains containing caveolin, and pravastatin, an inhibitor of
microdomain formation, partially inhibited the secretion of
DJ-1, suggesting that some DJ-1 was secreted through micro-
domains.
The microdomain or lipid rafts is a small region in the mem-
brane. Recent ﬁndings suggest that microdomains are a region
that plays a role in the proper signaling cascade and that abro-
gation of microdomain formation leads to the onset of various
diseases, including cancer. Proteins that participate in growth
signal transduction, such as Src family kinases, should be lo-
cated in microdomains to transmit correct growth signals
[39]. Oxidative signals also use microdomains to modulate for-
mation of oxidants [40]. Microdomains are also known to act
as sites of secretion in neural and immunological synaptic rela-
tions. Specialized cell surface regions such as microdomains
contact to directly convey and transduce highly controlled
secretory signals [41]. Since DJ-1 is an oxidative stress-related
protein and is located in the synapse, investigation of the roles
of microdomain-resident DJ-1 is important to determine the
function of DJ-1 in the pathogenesis of Parkinsons disease.
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